As of May 2023 Ionis Pharmaceuticals has a market cap of $5.78 Billion. This makes Ionis Pharmaceuticals the world's 2171th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $5.78 B | 7.83% |
2022 | $5.36 B | 24.86% |
2021 | $4.29 B | -45.65% |
2020 | $7.90 B | -6.75% |
2019 | $8.47 B | 13.7% |
2018 | $7.45 B | 18.79% |
2017 | $6.27 B | 8.28% |
2016 | $5.79 B | -22.22% |
2015 | $7.45 B | 1.92% |
2014 | $7.31 B | 57.59% |
2013 | $4.64 B | 337.98% |
2012 | $1.05 B | 47.34% |
2011 | $0.71 B | -28.51% |
2010 | $1.00 B | -8.41% |
2009 | $1.09 B | -20.16% |
2008 | $1.37 B | 0.11% |
2007 | $1.37 B | 50.17% |
2006 | $0.91 B | 141.85% |
2005 | $0.37 B | 11.62% |
2004 | $0.33 B | -6.14% |
2003 | $0.36 B | -0.76% |
2002 | $0.36 B | -69.49% |
2001 | $1.19 B |
On May 30th, 2023 the market cap of Ionis Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | $39.69 M | -99.31% | Bahamas |
![]() NRC Health
NRC | $1.08 B | -81.24% | ๐บ๐ธ USA |